1. Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment.
- Author
-
Cheng YH, Ko YC, Chang YF, Huang SH, and Liu CJ
- Subjects
- Animals, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Anti-Inflammatory Agents, Non-Steroidal chemistry, Antihypertensive Agents administration & dosage, Apoptosis, Blotting, Western, Cells, Cultured, Chitosan chemistry, Curcumin chemistry, Drug Combinations, Epithelium, Corneal drug effects, Epithelium, Corneal metabolism, Epithelium, Corneal pathology, Gelatin chemistry, Humans, Hydrogels, Hydrogen Peroxide toxicity, In Situ Nick-End Labeling, Mitochondria metabolism, Nanoparticles administration & dosage, Oxidative Stress, Particle Size, Rabbits, Reactive Oxygen Species metabolism, Trabecular Meshwork drug effects, Trabecular Meshwork metabolism, Trabecular Meshwork pathology, Chitosan administration & dosage, Curcumin administration & dosage, Drug Delivery Systems, Gelatin administration & dosage, Glaucoma drug therapy, Latanoprost administration & dosage, Temperature
- Abstract
Elevated intraocular pressure (IOP) in glaucoma is due to impairment of aqueous humor drainage via the uveoscleral or trabecular outflow pathway. Latanoprost reduces IOP by increasing the uveoscleral outflow. Despite its potency, long-term daily application of it may cause undesirable side effects and many require more than one medication for IOP control. Recent studies have suggested that oxidative stress in the trabecular meshwork (TM) play an important role in the pathogenesis of impaired trabecular outflow facility. Curcumin, a natural phenolic compound, possesses anti-oxidant and anti-inflammation properties. In this study, we developed a thermosensitive hydrogel containing latanoprost and curcumin-loaded nanoparticles (CUR-NPs), and evaluated its possible therapeutic effects with cultured human TM cells under oxidative stress. The results demonstrated that 20 μM of CUR-NPs might be the optimal concentration to treat TM cells without causing cytotoxicity. Using the newly developed system, both latanoprost and CUR-NPs displayed a sustained-release profile. Treatment with this hydrogel containing CUR-NPs effectively decreased the oxidative stress-mediated damage in TM cells via decreasing inflammation-related gene expression, mitochondrial reactive oxygen stress (ROS) production and apoptosis level. The in vivo biocompatibility revealed no signs of inflammation or damage after topical application of developed hydrogel in rabbits. These results suggest that this dual-drug delivery system might enhance both trabecular and uveoscleral outflow and is promising to develop into a novel treatment for glaucoma., (Copyright © 2018. Published by Elsevier Ltd.) more...
- Published
- 2019
- Full Text
- View/download PDF